China In Vivo Cro Market Size & Outlook, 2024-2030

The in vivo cro market in China is expected to reach a projected revenue of US$ 188.6 million by 2030. A compound annual growth rate of 9.1% is expected of China in vivo cro market from 2025 to 2030.
Revenue, 2024 (US$M)
$111.9
Forecast, 2030 (US$M)
$188.6
CAGR, 2025 - 2030
9.1%
Report Coverage
China

China in vivo cro market highlights

  • The China in vivo cro market generated a revenue of USD 102.7 million in 2023 and is expected to reach USD 188.6 million by 2030.
  • The China market is expected to grow at a CAGR of 9.1% from 2024 to 2030.
  • In terms of segment, small molecule was the largest revenue generating modality type in 2023.
  • Large Molecule is the most lucrative modality type segment registering the fastest growth during the forecast period.


In vivo cro market data book summary

Market revenue in 2023USD 102.7 million
Market revenue in 2030USD 188.6 million
Growth rate9.1% (CAGR from 2023 to 2030)
Largest segmentSmall molecule
Fastest growing segmentLarge Molecule
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationSmall Molecule, Large Molecule
Key market players worldwideIQVIA Holdings Inc, JSR Corp, Taconic Biosciences, Evotec SE, Janvier Labs, Charles River Laboratories International Inc, Icon PLC, Labcorp Holdings Inc, PAREXEL, GemPharmatech, PsychoGenics, Biocytogen, SMO-Group


Other key industry trends

  • In terms of revenue, China accounted for 2.2% of the global in vivo cro market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, Japan in vivo cro market is projected to lead the regional market in terms of revenue in 2030.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 122.7 million by 2030.

Small molecule was the largest segment with a revenue share of 63.58% in 2024. Horizon Databook has segmented the China in vivo cro market based on small molecule, large molecule covering the revenue growth of each sub-segment from 2018 to 2030.


The growing demand for in vivo services in China can be underpinned by low operational costs, investments to improve technology, R&D capacity building, and adherence to global R&D standards & guidelines to meet international requirements.

Consequently, several players are outsourcing their preclinical services to Chinese firms, benefitting from the government’s effort to create a conducive environment for conducting preclinical studies that align with global standards and satisfy regulatory bodies.

This support from the government enhances the credibility and reliability of in vivo CRO services in China. Furthermore, operating in the drug discovery sector in China offers a significant advantage in terms of lower costs.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

In Vivo CRO Market Scope

In vivo cro market segmentation & scope
Small Molecule
CAR T-cell therapies
CAR-NK cell therapy
TCR-T cell therapy
Others
RNA Therapy
Others
Non GLP
GLP Toxicology
Rat Models
Mice Models
Others
Non-Rodent based
Indication
Autoimmune/inflammation conditions
Rheumatoid Arthritis
Multiple Sclerosis
Osteoarthritis
Irritable Bowel Syndrome
Others
Pain management
Chronic pain
Acute pain
Oncology
Blood cancer
Solid tumor
Syngeneic model
Patient derived xenograft
Xenograft
Others
CNS Conditions
Epilepsy
Parkinson's disease
Huntington's disease
Stroke
Muscular Dystrophy
Alzheimer's Disease
Traumatic brain injury
Amyotrophic lateral sclerosis (ALS)
Spinal Muscular Atrophy
Muscle regeneration
Other Neurodevelopment Disorders
Diabetes
Obesity
Others

In Vivo CRO Market Companies

Name Profile # Employees HQ Website

China in vivo cro market size, by modality type, 2018-2030 (US$M)

China In Vivo CRO Market Outlook Share, 2024 & 2030 (US$M)

China in vivo cro market size, by modality type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more